Jill L. Reiter

1.2k citations
35 papers · 847 indexed · h-index 15
Topics
HER2/EGFR in Cancer Research (9 papers)RNA Research and Splicing (9 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)

In The Last Decade

Jill L. Reiter

35 papers receiving 831 citations

Peers

Jill L. Reiter
Comparison fields: 5 of 100
  • Molecular Biology 384
  • Oncology 227
  • Plant Science 133
  • Cancer Research 129
  • Pollution 127
Replace Zhulin Yang with:
Zhulin Yang China
Laura San‐Segundo Spain
Çagatay Güneş Germany
Gloria Chepko United States
Thomas Moulton United States
Kimberly Batten United States
Parvin Mehdipour Iran
J. Szymańska Poland
Chian‐Feng Chen Taiwan
Hélène Buteau-Lozano France
Jill L. Reiter relative to Zhulin Yang China Zhulin Yang's profile →
Citations per field
00.5×4.8×
Zhulin Yang · 1×
Citations per year

Countries citing papers authored by Jill L. Reiter

Since Specialization
Citations

This map shows the geographic impact of Jill L. Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill L. Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill L. Reiter more than expected).

Fields of papers citing papers by Jill L. Reiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill L. Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill L. Reiter. The network helps show where Jill L. Reiter may publish in the future.

Co-authorship network of co-authors of Jill L. Reiter

This figure shows the co-authorship network connecting the top 25 collaborators of Jill L. Reiter. A scholar is included among the top collaborators of Jill L. Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill L. Reiter. Jill L. Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 2
3 8
4 5
5 1
6 25
7 13
8 2
9 7
10 5
11 41
12 18
13 3
14 141
15 9
16 67
17 7
18 10
19 91
20 16

About Jill L. Reiter

Jill L. Reiter is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 35 papers that have together received 847 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), RNA Research and Splicing (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Pollution (127 citations), Cancer Research (129 citations) and Oncology (227 citations). Jill L. Reiter has collaborated with scholars based in United States, China and Puerto Rico. Frequent co-authors include Nita J. Maihle, Garrett M. Brodeur, Roy Gerona, Paul Winchester, Shahid Parvez, Yunlong Liu, Andre T. Baron, C. David James, Greg Eley and Jacqueline M. Lafky. Their work appears in journals such as Nucleic Acids Research, Oncogene and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026